Search

A recent study found that high levels of urinary cadmium are linked to a doubled risk of global cognitive impairment in White adults, but not in Black adults. The study, which included 2172 participants, highlighted the importance of reducing cadmium exposure through policy changes and individual behavior modifications. While the findings suggest a potential association between cadmium exposure and cognitive impairment, further research is needed to confirm these results and explore long-term effects. [Extracted from the article]

A recent meta-analysis published in Clinical Psychiatry News found that bright light therapy (BLT) is associated with a 41% remission rate in patients with nonseasonal depressive disorders, higher than other treatments. The study included 11 randomized clinical trials with 858 patients and showed that BLT was more effective in achieving remission and response to treatment compared to control groups. The findings suggest that BLT could be an effective adjunctive treatment for nonseasonal depressive disorders, potentially improving response time to initial treatment. [Extracted from the article]

A new study suggests that the likelihood of receiving a dementia diagnosis in older adults varies significantly by region across the United States. Rates ranged from 1.7% to 5.4%, with variations more pronounced in those aged 66-74 years and Black or Hispanic individuals. The study analyzed newly diagnosed cases of Alzheimer's disease and related dementias using Medicare claims data for 4.8 million older adults across 306 hospital referral regions. Regional differences in diagnosis rates are not fully explained by population risk factors, indicating potential health system-level differences. The study was supported by a grant from the National Institute on Aging. [Extracted from the article]

A new study has found that treatment-resistant major depression (TRD) is associated with a 17% higher risk of all-cause mortality compared to non-TRD major depressive disorder (MDD). The increased mortality risk is primarily driven by suicide and accidental overdose, which are nearly twice as high among individuals whose depression does not improve after two treatments. The study analyzed data from 176,942 individuals diagnosed with MDD and treated with an antidepressant, with a median follow-up period of 8.9 years. The findings suggest that individuals with TRD may experience more intense symptoms and severe suicidal ideation. However, it is important to note that the definition of TRD lacked consensus, and the study used routine data that may not have captured all relevant clinical nuances. The study was funded by Johnson & Johnson Innovative Medicine and Niuvanniemi Hospital, with support from the Finnish Ministry of Social Affairs and Health. [Extracted from the article]

A new study suggests that a history of migraine in women is not associated with an increased risk of Parkinson's disease (PD), regardless of headache frequency or migraine subtype. The study analyzed data from 39,312 women health professionals aged 45 years and older who had no history of PD. During the study period, 685 women self-reported a diagnosis of PD, with 18.7% of cases in women with any migraine and 81.3% in women without migraine. The findings provide reassurance to women with migraines that they do not have to worry about an elevated risk of PD in the future. However, the study's limitations include potential inaccuracies in self-reported data and the lack of accounting for changes in migraine status and frequency over time. The study's findings may not be generalizable to other populations, such as men and non-White individuals. [Extracted from the article]